Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada · Delayed Price · Currency is CAD 0.1000
+0.0100 (11.11%)
Jun 9, 2026, 5:19 PM EST
Rapid Dose Therapeutics Market Cap
Rapid Dose Therapeutics has a market cap or net worth of CAD 13.64 million as of June 10, 2026. Its market cap has decreased by -47.33% in one year.
Market Cap
13.64M
Enterprise Value
19.30M
Revenue
2.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since December 17, 2018, Rapid Dose Therapeutics's market cap has decreased from 63.77M to 13.64M, a decrease of -78.60%. That is a compound annual growth rate of -18.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 9, 2026 | 13.64M | -22.70% |
| Dec 31, 2025 | 17.65M | -37.53% |
| Dec 31, 2024 | 28.26M | 63.18% |
| Dec 29, 2023 | 17.32M | -67.57% |
| Dec 31, 2021 | 53.40M | 110.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 17, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Thiogenesis Therapeutics | 31.10M |
| Devonian Health Group | 31.01M |
| Pharmala Biotech Holdings | 17.42M |
| Marvel Biosciences | 12.29M |
| Britannia Life Sciences | 12.17M |
| Hemostemix | 10.88M |
| Glow Lifetech | 9.62M |
| COSCIENS Biopharma | 9.23M |